Joaquin Duato, J&J CEO (David Zorrakino/Europa Press via Getty Images)
J&J notebook: Highlights from a day of pipeline and strategy discussion
Johnson & Johnson laid out their pipeline and medtech strategies Tuesday, promising 20 new drugs that can help grow sales 5% to 7% a year …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
